Prolonged Survival of Tumor-bearing Rats with Repetitive Low-Dose Recombinant Tumor Necrosis Factor

作者: Fraker Dl , Langstein Hn , Venzon D , Norton Ja , Sheppard Bc

DOI:

关键词:

摘要: Tumor necrosis factor may be a mediator of the syndrome cancer cachexia. Tachyphylaxis or tolerance to cachectic effects recombinant tumor (rTNF) has been previously described. In this study, we investigate whether repetitive exposure rTNF can induce similar in tumor-bearing (TB) rats and ameliorate cachexia induced by tumor. experiment 1, non-tumor-bearing (NTB) TB were randomized either escalating low doses saline i.p. twice daily for 9 consecutive days. NTB treated with demonstrated significant decline food intake weight change ( P < 0.00001) but soon developed rTNF; they consumed significantly more than on first day treatment had saline. showed 0.0001) also continued treatment. Following treatment, that ate lost less 0.00001). antineoplastic activity, as estimated tumors from controls = 0.003). The anticachexia resulted prolonged survival compared control 0.015). Experiment 2 utilized two different regimens rats: one group received 12 days rTNF, another 15 again greater delayed loss posttreatment was further augmented additional rTNF. Antineoplastic activity clear, overall growth curves not affected Survival increased dose-dependent manner 0.006). Repeated administration induces mild reduction growth, results tumor, prolongation survival.

参考文章(30)
Steven A. Leadon, Anthony Chan, Robert J. Zimmerman, Oxidative damage in murine tumor cells treated in vitro by recombinant human tumor necrosis factor Cancer Research. ,vol. 49, pp. 1644- 1648 ,(1989)
Barbara A. Sherry, Johan Gelin, Yuman Fong, Michael Marano, He Wei, Anthony Cerami, Stephen F. Lowry, Kent G. Lundholm, Lyle L. Moldawer, Anticachectin/tumor necrosis factor-alpha antibodies attenuate development of cachexia in tumor models. The FASEB Journal. ,vol. 3, pp. 1956- 1962 ,(1989) , 10.1096/FASEBJ.3.8.2721856
J Bartholeyns, M Freudenberg, C Galanos, Growing tumors induce hypersensitivity to endotoxin and tumor necrosis factor. Infection and Immunity. ,vol. 55, pp. 2230- 2233 ,(1987) , 10.1128/IAI.55.9.2230-2233.1987
Yaron Nophar, Helmut Holtmann, David Wallach, Hartmut Engelmann, Sensitization and desensitization to lethal effects of tumor necrosis factor and IL-1. Journal of Immunology. ,vol. 140, pp. 2994- 2999 ,(1988)
K J Tracey, H Wei, K R Manogue, Y Fong, D G Hesse, H T Nguyen, G C Kuo, B Beutler, R S Cotran, A Cerami, Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. Journal of Experimental Medicine. ,vol. 167, pp. 1211- 1227 ,(1988) , 10.1084/JEM.167.3.1211
Mark C. Stovroff, Cachectin Activity in the Serum of Cachectic, Tumor-Bearing Rats Archives of Surgery. ,vol. 124, pp. 94- 99 ,(1989) , 10.1001/ARCHSURG.1989.01410010104021
K. Pfizenmaier, M. Kr�nke, P. Scheurich, G. A. Nagel, Tumor necrosis factor (TNF) alpha: control of TNF-sensitivity and molecular mechanisms of TNF-mediated growth inhibition. Annals of Hematology. ,vol. 55, pp. 1- 10 ,(1987) , 10.1007/BF00319635
Bruce Beutler, Anthony Cerami, Cachectin and tumour necrosis factor as two sides of the same biological coin Nature. ,vol. 320, pp. 584- 588 ,(1986) , 10.1038/320584A0
Jeffrey A. Norton, Michelle Maher, Robert Wesley, Donald White, Murray F. Brennan, Glucose intolerance in sarcoma patients Cancer. ,vol. 54, pp. 3022- 3027 ,(1984) , 10.1002/1097-0142(19841215)54:12<3022::AID-CNCR2820541234>3.0.CO;2-K
Philip Scuderi, KitS. Lam, KennethJ. Ryan, Eskild Petersen, KarenE. Sterling, PaulR. Finley, C.George Ray, DonaldJ. Slymen, SydneyF. Salmon, RAISED SERUM LEVELS OF TUMOUR NECROSIS FACTOR IN PARASITIC INFECTIONS The Lancet. ,vol. 328, pp. 1364- 1365 ,(1986) , 10.1016/S0140-6736(86)92007-6